Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 3,801–3,820 of 17,937 drug recalls

Drug Recall Terminated Historical recordClass II

Propofol Injectable Emulsion, USP 200 mg per 20 mL (10 mg per mL), twenty-five 20 mL vials, Rx only, MFG: Teva Pharma USA, NDC 0591-2136-95

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Propofol Injectable Emulsion, USP, 200 mg/ 20 mL (10 mg/mL), packaged in a) 50 mL vial, in packs of 20 (NDC 00591-2136-51), b) 100 mL vial, in packs of 10 (NDC 00591-2136-68), Rx only, MFG: Teva Pharma USA

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Proair, HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation, 200 metered inhalations, Rx only, MFG: Teva Pharma USA, NDC 59310-579-22

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Mupirocin Ointment, USP 2%, 22 grams tube, Rx only, MFG: Teva Pharma USA, NDC 0093-1010-42, MFG: Teva Pharma USA

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/5mL (80 mg/mL), 5 mL multi-dose vials, Rx only, MFG: Teva Pharma USA, NDC 0703-0063-01

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

MethyLPREDNISolone Acetate Injectable Suspension USP, 80 mg/mL, packaged in a) 1 mL single dose vial (NDC 0703-0051-01) b) 25-count box (NDC 0703-0051-04), Rx only, MFG: Teva Pharma USA

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/10 mL (40 mg/mL), 10 mL multi-dose vial, Rx only, MFG: Teva Pharma USA, NDC 0703-0045-01

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

MethyLPREDNISolone Acetate Injectable Suspension, USP, 200mg/5mL (40 mg/mL), 5 mL multi-dose vial, Rx only, MFG: Teva Pharma USA, NDC 0703-0043-01

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

MethyLPREDNISolone Acetate Injectable Suspension, USP, 40 mg/mL, packaged in a) 1 mL single dose vial (NDC 0703-0031-01), b) 25-count box (NDC 0703-0031-04), Rx only, MFG: Teva Pharma USA

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Medroxyprogesterone acetate injectable suspension, USP, 150 mg/mL, 1 mL vials, packaged in a) single dose vial (NDC 0703-6801-01), b) 25-count box single dose vials (NDC 0703-6801-04), Rx only, MFG: Teva Pharma USA

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine Patch 5%, 30-count box, Rx only, MFG: Teva Pharma USA, NDC 0591-3525-30

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Levalbuterol Tartrate HFA Inhalation Aerosol, 45 mcg/actuation, 200 metered inhalations, Rx only, MFG: Teva Pharma USA, NDC 0591-2927-54

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottle, Rx only, MFG: Teva/Actavis, NDC 00228-2127-10

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Ketoconazole Cream, 2%, Net Wt 60 grams tube, Rx only, MFG: Nycomed Inc, NDC 0168-0099-60

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/5 mL (80 mg/mL), 5 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-473-01

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

MethyLPREDNISolone Acetate Injectable Suspension, USP, 400 mg/10 mL (40 mg/mL), 10 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-090-01

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

MethyLPREDNISolone Acetate Injectable Suspension, USP, 200 mg/5 mL (40 mg/mL), 5 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA , NDC 16714-089-01

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

MethyLPREDNISolone Acetate Injectable Suspension USP, 40 mg/mL, packaged in a) single dose vial (NDC 6714-088-01) b) 25-count box (NDC16714-088-25), Rx only, MFG: NorthstarRx/Teva Pharma USA

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Medroxyprogesterone acetate injectable suspension, 150 mg/mL, 1 mL single dose vial, Rx only, MFG: NorthStarRx/Teva Pharma USA , NDC 16714-981-01

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Sulfamethoxazole and Trimethoprim Tablets, USP, 800mg/160mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-2725-61

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.